These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 8738192)
1. Determination of apovincaminic acid in human plasma by high-performance liquid chromatography. Maya MT; Pais JP; Araújo HM; Morais JA J Pharm Biomed Anal; 1996 Mar; 14(5):617-22. PubMed ID: 8738192 [TBL] [Abstract][Full Text] [Related]
2. Determination of apovincaminic acid in serum by means of high-performance liquid chromatography. Kraus G; Schulz HU; Lohmann A J Chromatogr; 1992 Jan; 573(2):323-7. PubMed ID: 1601968 [TBL] [Abstract][Full Text] [Related]
3. Determination of apovincaminic acid in human plasma by high-performance liquid chromatography using solid-phase extraction and ultraviolet detection. Chen J; Cai J; Tao W; Mei N; Cao S; Jiang X J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Jan; 830(2):201-6. PubMed ID: 16321580 [TBL] [Abstract][Full Text] [Related]
4. Determination of apovincaminic acid in biological samples by high-performance liquid chromatography. Kozma M; Pudleiner P; Vereczkey L J Chromatogr; 1982 May; 241(1):177-82. PubMed ID: 7107794 [TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and comparative bioavailability of two vinpocetine tablet formulations in healthy volunteers by using the metabolite apovincaminic acid as pharmacokinetic parameter. Vlase L; Bodiu B; Leucuta SE Arzneimittelforschung; 2005; 55(11):664-8. PubMed ID: 16366040 [TBL] [Abstract][Full Text] [Related]
6. Determination of vinpocetine and its primary metabolite, apovincaminic acid, in rat plasma by liquid chromatography-tandem mass spectrometry. Xia HM; Su LN; Guo JW; Liu GM; Pang ZQ; Jiang XG; Chen J J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Jul; 878(22):1959-66. PubMed ID: 20561830 [TBL] [Abstract][Full Text] [Related]
7. Simultaneous Determination of Vinpocetine and its Major Active Metabolite Apovincaminic Acid in Rats by UPLC-MS/MS and its Application to the Brain Tissue Distribution Study. Wang M; Wang L; Sun J; Zhang L; Zhao L; Xiong Z J Chromatogr Sci; 2018 Mar; 56(3):225-232. PubMed ID: 29206914 [TBL] [Abstract][Full Text] [Related]
8. Determination of apovincaminic acid in human plasma by gas-liquid chromatography. Polgár M; Vereczkey L J Chromatogr; 1982 May; 241(1):29-32. PubMed ID: 7107795 [TBL] [Abstract][Full Text] [Related]
9. Determination of the antidepressant fluoxetine in human plasma by LC with UV detection. Maya MT; Domingos CR; Guerreiro MT; Morais JA J Pharm Biomed Anal; 2000 Nov; 23(6):989-96. PubMed ID: 11095300 [TBL] [Abstract][Full Text] [Related]
10. Quantitative determination of puerarin in dog plasma by HPLC and study on the relative bioavailability of sustained release tablets. Ren F; Jing Q; Shen Y; Ma H; Cui J J Pharm Biomed Anal; 2006 May; 41(2):549-53. PubMed ID: 16413737 [TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of vinpocetine and its main metabolite apovincaminic acid before and after the chronic oral administration of vinpocetine to humans. Miskolczi P; Kozma K; Polgár M; Vereczkey L Eur J Drug Metab Pharmacokinet; 1990; 15(1):1-5. PubMed ID: 2384112 [TBL] [Abstract][Full Text] [Related]
12. Study on the absorption of vinpocetine and apovincaminic acid. Pudleiner P; Vereczkey L Eur J Drug Metab Pharmacokinet; 1993; 18(4):317-21. PubMed ID: 8020528 [TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of apovincaminic acid in dogs. Vereczkey L; Pudleiner P Pol J Pharmacol Pharm; 1987; 39(2):161-5. PubMed ID: 3432163 [TBL] [Abstract][Full Text] [Related]
14. New HPLC-MS method for quantitative determination of apovincaminic acid in human plasma. Vlase L; Imre S; Leucuta S J Sep Sci; 2006 Feb; 29(3):385-9. PubMed ID: 16544880 [TBL] [Abstract][Full Text] [Related]
15. Effect of age on the pharmacokinetics of vinpocetine (Cavinton) and apovincaminic acid. Miskolczi P; Vereczkey L; Szalay L; Göndöc C Eur J Clin Pharmacol; 1987; 33(2):185-9. PubMed ID: 3691609 [TBL] [Abstract][Full Text] [Related]
16. Improved gas chromatographic-mass spectrometric method for the quantitative determination of vinpocetine in human plasma. Vatsova M; Tzvetanov S; Drenska A; Goranscheva J; Tyutyulkova N J Chromatogr B Biomed Sci Appl; 1997 Nov; 702(1-2):221-6. PubMed ID: 9449575 [TBL] [Abstract][Full Text] [Related]
17. Simultaneous evaluation of apovincaminic acid esters and their metabolite apovincaminic acid by solvent partition and GLC in biological samples. Preliminary data with MR 711. Marzo A; Quadro G; Stradi R; Saccarello ML; Molteni L; Bruno G Arzneimittelforschung; 1981; 31(10):1681-4. PubMed ID: 7198444 [TBL] [Abstract][Full Text] [Related]
18. Lack of pharmacokinetic interaction between vinpocetine and oxazepam. Storm G; Oosterhuis B; Sollie FA; Visscher HW; Sommer W; Beitinger H; Jonkman JH Br J Clin Pharmacol; 1994 Aug; 38(2):143-6. PubMed ID: 7981015 [TBL] [Abstract][Full Text] [Related]
19. Enantioselective high-performance liquid chromatographic determination of nicardipine in human plasma. Uno T; Ohkubo T; Sugawara K J Chromatogr B Biomed Sci Appl; 1997 Sep; 698(1-2):181-6. PubMed ID: 9367206 [TBL] [Abstract][Full Text] [Related]
20. Quantitative determination of vinpocetine in human plasma by capillary gas chromatography-mass spectrometry. Hammes W; Weyhenmeyer R J Chromatogr; 1987 Jan; 413():264-9. PubMed ID: 3558678 [No Abstract] [Full Text] [Related] [Next] [New Search]